Blauvelt, In this Issue–Full Court Press on Psoriasis, The Journal of Investigative
Dermatology, pp. vii-viii (2004). Bloom et al., Intrachain disulfide bond in the core hinge …

As biologic therapies become first line treatments for many inflammatory disorders, it
becomes increasingly important for the practicing physician to be familiar with how these …

DiCE Molecules is setting its sights on the clinic. With $80 million raised (https://www.
businesswire. com/news/home/20210108005060/en/DiCE-Molecules-Announces-80 …

Protein Design Labs Inc (PDL) is developing SMART anti-CD3 (Nuvion) as a potential
therapeutic for autoimmune diseases such as inflammatory bowel disease (IBD), and as a …

Cytokine immunocomplexes (non-covalent complexes of given cytokine and a
corresponding monoclonal antibody recognizing that cytokine) and immunocytokines (fusion …

First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
50336511&utm_source= google_patent&utm_medium= platform_link&utm_campaign …

● Interleukin-13 (IL-13) is a T helper type 2 (Th2) cytokine that plays a key role in the
pathogenesis of atopic dermatitis, asthma, and other inflammatory and immunologic …

Newly released data from the first drug to exclusively inhibit the pro-inflammatory cytokine
interleukin-23 (IL-23) show similar clinical benefit to other recently approved biological …